Julie C. Crockett - Concepedia

Author

Julie C. Crockett

University of Aberdeen

Also Known As

J C Crockett, J Crockett, J. C. Crockett, J.C. Crockett, Julie C Crockett, Julie C. Crockett, Julie Crockett

Publications

Citations

H-Index

Concepts

All Affiliations

University of Aberdeen GW Pharmaceuticals (United Kingdom)Great Ormond Street Hospital University of Edinburgh Royal Observatory in Greenwich

About

Julie C. Crockett is an author at University of Aberdeen specializing in medicine, health sciences, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	560
2	Health Sciences	3	3	183
3	Endocrinology	2	2	99
4	Natural Sciences	1	1	13
5	Biochemistry	1	1	13

Julie C. Crockett

Publications

Citations

H-Index

Page 1

	Year	Citations
Bone remodelling at a glance Julie C. Crockett, Michael J. Rogers, Fraser P. Coxon, Journal of Cell Science	2011	483
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations Matteo M. Guerrini, Cristina Sobacchi, Barbara Cassani, The American Journal of Human Genetics Bone DiseaseRheumatologyImmunologyPathologyHuman Osteoclast-poor Osteopetrosis	2008	299
Cytosolic Entry of Bisphosphonate Drugs Requires Acidification of Vesicles after Fluid-Phase Endocytosis Keith Thompson, Michael J. Rogers, Fraser P. Coxon, Molecular Pharmacology	2006	240
A Phase 1, Open‐Label, Pharmacokinetic Trial to Investigate Possible Drug‐Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects Gilmour Morrison, Julie C. Crockett, Graham Blakey, Clinical Pharmacology in Drug Development	2019	195
Increase in NF-κB Binding Affinity of the Variant C Allele of the Toll-Like Receptor 9 −1237T/C Polymorphism Is Associated with <i>Helicobacter pylori</i> -Induced Gastric Disease Mike T. Ng, Rob vanʼt Hof, Julie C. Crockett, Infection and Immunity	2009	105
A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment Lesley Taylor, Julie C. Crockett, Bola Tayo, The Journal of Clinical Pharmacology Severe Hepatic ImpairmentPharmacotherapyCannabinoid PharmacologyTotal CbdTandem Mass Spectrometry	2019	98
Zoledronic acid induces formation of a pro‐apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts <i>in vivo</i> and in MCF‐7 cells <i>in vitro</i> Johanna Räikkönen, Julie C. Crockett, Michael J. Rogers, British Journal of Pharmacology	2009	77
RANK-dependent autosomal recessive osteopetrosis: Characterization of five new cases with novel mutations Alessandra Pangrazio, Barbara Cassani, Matteo M. Guerrini, Journal of Bone and Mineral Research	2011	76
A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects Julie C. Crockett, David Critchley, Bola Tayo, Epilepsia	2020	72
A Comparison between the Effects of Hydrophobic and Hydrophilic Statins on Osteoclast Function In Vitro and Ovariectomy-Induced Bone Loss In Vivo Alun D. Hughes, Michael J. Rogers, Aymen I. Idris, Calcified Tissue International SclerostinHydrophilic StatinsOsteoclast FunctionGynecologyOsteoarthritis	2007	65

Page 1